Uterine Sarcoma Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Role of microRNAs in glycolysis in gynecological tumors (Review)
Int J Oncol. 2023 May;62(5):63. doi: 10.3892/ijo.2023.5511. Epub 2023 Apr 13.ABSTRACTGynecological malignancies are a leading cause of mortality among females worldwide, and difficulties in early diagnosis and acquired drug resistance constitute obstacles to effective therapies. Ovarian cancer causes more deaths than any other cancer of the female reproductive system. Specifically, in females aged 20 to 39 years, cervical cancer is the third leading cause of cancer‑related mortality, and the incidence rates of cervical adenocarcinoma are increasing. Endometrial carcinoma is the most common gynecological cancer in develop...
Source: International Journal of Oncology - April 13, 2023 Category: Cancer & Oncology Authors: Qianying Chen Siyi Shen Nengyuan Lv Jinyi Tong Source Type: research

Current Concepts in the Imaging of Uterine Sarcomas
Uterine sarcomas are a group of rare uterine tumors comprised of multiple subtypes with different histologic characteristics, prognoses, and imaging appearances. Identification of uterine sarcomas and their differentiation from benign uterine disease on imaging is of critical importance for treatment planning to guide appropriate management and optimize patient outcomes. Herein, we review the spectrum of uterine sarcomas with a focus on the classification of primary sarcoma subtypes and presenting the typical MR imaging appearances. (Source: Radiologic Clinics of North America)
Source: Radiologic Clinics of North America - April 4, 2023 Category: Radiology Authors: Robert Petrocelli, Nicole Hindman, Caroline Reinhold Source Type: research

Endometrial stromal sarcoma: French Guidelines from the French Sarcoma Group and the Rare Malignant Gynecologic Tumors Group
Bull Cancer. 2023 Mar 27:S0007-4551(23)00141-8. doi: 10.1016/j.bulcan.2023.03.003. Online ahead of print.ABSTRACTLow-grade endometrial stromal sarcoma (LG-ESS) accounts for approximately 15% of all uterine sarcomas. Median age of patients is around 50 years and half of the patients are premenopausal. In all, 60% of cases present with FIGO stage I disease. Preoperatively radiologic findings of ESS are not specific. Pathological diagnosis remains essential. This review aimed to present the French guidelines for low grade ESS treatment within the Groupe sarcome français - Groupe d'étude des tumeurs osseuse (GSF-GETO)/NETSAR...
Source: Bulletin du Cancer - March 29, 2023 Category: Cancer & Oncology Authors: Coriolan Lebreton Pierre Meeus Catherine Genestie Sabrina Croce Fr édéric Guyon Carmen Llacer Moscardo Sophie Taieb Jean-Yves Blay Sylvie Bonvalot Emmanuelle Bompas Christine Chevreau Fabrice L écuru L éa Rossi Florence Joly Maria Rios Lo ïc Chaignea Source Type: research